Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Examining Urban and Rural Differences in How Distance to Care Influences the Initiation and Completion of Treatment among Insured Cervical Cancer Patients.

Spees LP, Brewster WR, Varia MA, Weinberger M, Baggett C, Zhou X, Petermann VM, Wheeler SB.

Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):882-889. doi: 10.1158/1055-9965.EPI-18-0945. Epub 2019 Feb 7.

PMID:
30733307
2.

Effect of race and histology on patterns of failure in women with early stage endometrial cancer treated with high dose rate brachytherapy.

Ozen A, Falchook AD, Varia MA, Gehrig P, Jones EL.

Gynecol Oncol. 2015 Aug;138(2):429-33. doi: 10.1016/j.ygyno.2015.05.025. Epub 2015 May 27.

PMID:
26024766
3.

ACR appropriateness Criteria® advanced stage endometrial cancer.

Elshaikh MA, Yashar CM, Wolfson AH, Cardenes HR, Erickson B, Jhingran A, Jolly S, Kidd E, Lee LJ, Mayr NA, Moore D, Rao GG, Small W Jr, Varia MA, Wahl AO, Yuh W, Gaffney DK; Expert Panel on Radiation Oncology-Gynecology:.

Am J Clin Oncol. 2014 Aug;37(4):391-6. doi: 10.1097/COC.0000000000000098.

PMID:
24977691
4.

Acr appropriateness Criteria management of vaginal cancer.

Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, Mayr NA, Moore D, Puthawala AA, Rao GG, Small W Jr, Varia MA, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Gaffney DK.

Oncology (Williston Park). 2013 Nov;27(11):1166-73. Review.

5.

ACR Appropriateness Criteria® management of locoregionally advanced squamous cell carcinoma of the vulva.

Expert Panel on Radiation Oncology-Gynecology, Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W Jr, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes HR.

Am J Clin Oncol. 2013 Aug;36(4):415-22. doi: 10.1097/COC.0b013e318295af1d. Review.

PMID:
23872794
6.

Hypoxia regulation of phosphokinases and the prognostic value of pAKT in breast cancer.

Wennemers M, Stegeman H, Bussink J, Versleijen-Jonkers YM, van Laarhoven HW, Raleigh JA, Varia MA, Sweep FC, Span PN.

Int J Biol Markers. 2013 Jun 28;28(2):151-60. doi: 10.5301/jbm.5000008.

PMID:
23558942
7.

ACR Appropriateness Criteria® definitive therapy for early-stage cervical cancer.

Small W Jr, Strauss JB, Jhingran A, Yashar CM, Cardenes HR, Erickson-Wittmann BA, Gullett N, Kidd E, Lee LJ, Mayr NA, Moore D, Puthawala AA, Rao GG, Varia MA, Wahl AO, Wolfson AH, Yuh W, Gaffney DK.

Am J Clin Oncol. 2012 Aug;35(4):399-405. doi: 10.1097/COC.0b013e3182610537. Review.

PMID:
22810416
8.

ACR Appropriateness Criteria® pretreatment planning of invasive cancer of the cervix.

Siegel CL, Andreotti RF, Cardenes HR, Brown DL, Gaffney DK, Horowitz NS, Javitt MC, Lee SI, Mitchell DG, Moore DH, Rao GG, Royal HD, Small W Jr, Varia MA, Yashar CM; American College of Radiology.

J Am Coll Radiol. 2012 Jun;9(6):395-402. doi: 10.1016/j.jacr.2012.02.021.

PMID:
22632665
9.

ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancer.

Wolfson AH, Varia MA, Moore D, Rao GG, Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Small W Jr, Yashar CM, Yuh W, Cardenes HR; American College of Radiology (ACR).

Gynecol Oncol. 2012 Apr;125(1):256-62. doi: 10.1016/j.ygyno.2011.11.048. Epub 2011 Dec 7.

PMID:
22155418
10.

Endogenous myoglobin in breast cancer is hypoxia-inducible by alternative transcription and functions to impair mitochondrial activity: a role in tumor suppression?

Kristiansen G, Hu J, Wichmann D, Stiehl DP, Rose M, Gerhardt J, Bohnert A, ten Haaf A, Moch H, Raleigh J, Varia MA, Subarsky P, Scandurra FM, Gnaiger E, Gleixner E, Bicker A, Gassmann M, Hankeln T, Dahl E, Gorr TA.

J Biol Chem. 2011 Dec 16;286(50):43417-28. doi: 10.1074/jbc.M111.227553. Epub 2011 Sep 19.

11.

Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response.

Wennemers M, Bussink J, Scheijen B, Nagtegaal ID, van Laarhoven HW, Raleigh JA, Varia MA, Heuvel JJ, Rouschop KM, Sweep FC, Span PN.

Breast Cancer Res. 2011 Aug 24;13(4):R82. doi: 10.1186/bcr2934.

12.

ACR appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer of the uterus.

Lee JH, Dubinsky T, Andreotti RF, Cardenes HR, Dejesus Allison SO, Gaffney DK, Glanc P, Horowitz NS, Jhingran A, Lee SI, Puthawala AA, Royal HD, Scoutt LM, Small W Jr, Varia MA, Zelop CM; Expert Panel on Women's Imaging and Radiation Oncology-Gynecology.

Ultrasound Q. 2011 Jun;27(2):139-45. doi: 10.1097/RUQ.0b013e31821b6f73. Review.

PMID:
21606818
13.

ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on Radiation Oncology-Gynecology.

Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Moore D, Rao GG, Small W Jr, Varia MA, Wolfson AH, Yashar CM, Yuh W, Cardenes HR.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):609-14. doi: 10.1016/j.ijrobp.2010.11.005. Epub 2011 Jan 5. No abstract available.

PMID:
21215531
14.

Stereotactic body radiotherapy (SBRT): Technological innovation and application in gynecologic oncology.

Higginson DS, Morris DE, Jones EL, Clarke-Pearson D, Varia MA.

Gynecol Oncol. 2011 Mar;120(3):404-12. doi: 10.1016/j.ygyno.2010.11.042. Epub 2010 Dec 30. Review.

PMID:
21194733
15.
16.

Hypoxia and differentiation in squamous cell carcinomas of the uterine cervix: pimonidazole and involucrin.

Azuma Y, Chou SC, Lininger RA, Murphy BJ, Varia MA, Raleigh JA.

Clin Cancer Res. 2003 Oct 15;9(13):4944-52.

17.

Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.

Varia MA, Stehman FB, Bundy BN, Benda JA, Clarke-Pearson DL, Alvarez RD, Long HJ; Gynecologic Oncology Group.

J Clin Oncol. 2003 Aug 1;21(15):2849-55.

PMID:
12885800
18.

HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.

Janssen HL, Haustermans KM, Sprong D, Blommestijn G, Hofland I, Hoebers FJ, Blijweert E, Raleigh JA, Semenza GL, Varia MA, Balm AJ, van Velthuysen ML, Delaere P, Sciot R, Begg AC.

Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1537-49.

PMID:
12459383
19.

Functional significance of erythropoietin receptor expression in breast cancer.

Arcasoy MO, Amin K, Karayal AF, Chou SC, Raleigh JA, Varia MA, Haroon ZA.

Lab Invest. 2002 Jul;82(7):911-8.

20.

Semiquantitative immunohistochemical analysis for hypoxia in human tumors.

Raleigh JA, Chou SC, Bono EL, Thrall DE, Varia MA.

Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):569-74.

PMID:
11173156
21.

Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas.

Quattrocchi KB, Miller CH, Cush S, Bernard SA, Dull ST, Smith M, Gudeman S, Varia MA.

J Neurooncol. 1999;45(2):141-57.

PMID:
10778730
22.

A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas.

Raleigh JA, Chou SC, Calkins-Adams DP, Ballenger CA, Novotny DB, Varia MA.

Clin Cancer Res. 2000 Mar;6(3):855-62.

23.

Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.

Varia MA, Bundy BN, Deppe G, Mannel R, Averette HE, Rose PG, Connelly P.

Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):1015-23.

PMID:
9869224
24.

Relationship of hypoxia to metallothionein expression in murine tumors.

Raleigh JA, Chou SC, Tables L, Suchindran S, Varia MA, Horsman MR.

Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):727-30.

PMID:
9845085
25.

Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma.

Varia MA, Calkins-Adams DP, Rinker LH, Kennedy AS, Novotny DB, Fowler WC Jr, Raleigh JA.

Gynecol Oncol. 1998 Nov;71(2):270-7.

PMID:
9826471
26.

Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker.

Raleigh JA, Calkins-Adams DP, Rinker LH, Ballenger CA, Weissler MC, Fowler WC Jr, Novotny DB, Varia MA.

Cancer Res. 1998 Sep 1;58(17):3765-8.

27.

Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays.

Kennedy AS, Raleigh JA, Perez GM, Calkins DP, Thrall DE, Novotny DB, Varia MA.

Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):897-905.

PMID:
9128967
28.

Primary squamous cell carcinoma of the endometrium: a first report of adjuvant chemoradiation.

Kennedy AS, DeMars LR, Flannagan LM, Varia MA.

Gynecol Oncol. 1995 Oct;59(1):117-23. Review.

PMID:
7557596
29.

Invasive carcinoma of the uterine cervix in women age 25 or less.

Maddux HR, Varia MA, Spann CO, Fowler WC, Rosenman JG.

Int J Radiat Oncol Biol Phys. 1990 Sep;19(3):701-6.

PMID:
2211218
30.

A controlled study of efficacy of interstitial or external irradiation in a virus-induced brain-tumor model in rats.

el-Hennawi Y, Gillespie GY, Mahaley MS Jr, Varia MA, Bigner DD, Stanton C.

J Neurosurg. 1989 Dec;71(6):898-902.

PMID:
2555463
31.

Analysis of results of radiation therapy for stage IB carcinoma of the cervix.

Montana GS, Fowler WC, Varia MA, Walton LA, Mack Y.

Cancer. 1987 Nov 1;60(9):2195-200.

PMID:
3440229
32.

A spreadsheet program for brachytherapy planning.

Sherouse GW, Naves JL, Varia MA, Rosenman J.

Int J Radiat Oncol Biol Phys. 1987 Apr;13(4):639-46.

PMID:
3558054
33.

An integrated system for interstitial 192Ir implants.

Bourland JD, Reynolds KL, Chaney EL, Varia MA, Rosenman JG, McMurry HL, Simons AD.

Int J Radiat Oncol Biol Phys. 1987 Mar;13(3):455-63.

PMID:
3558032
34.

Effect of methylprednisolone on radiotherapy of F344 rats with avian sarcoma virus induced gliomas.

El-Hennawi Y, Gillespie GY, Varia MA, Watkins P, Mahaley MS Jr, Bigner DD.

J Neurooncol. 1987;4(3):309-13.

PMID:
3031229
35.

1000 cGy single dose palliation for advanced carcinoma of the cervix or endometrium.

Halle JS, Rosenman JG, Varia MA, Fowler WC, Walton LA, Currie JL.

Int J Radiat Oncol Biol Phys. 1986 Nov;12(11):1947-50.

PMID:
2429945
36.

Carcinoma of the cervix, stage III. Results of radiation therapy.

Montana GS, Fowler WC, Varia MA, Walton LA, Mack Y, Shemanski L.

Cancer. 1986 Jan 1;57(1):148-54.

PMID:
3940615
37.

Analysis of results of radiation therapy for Stage II carcinoma of the cervix.

Montana GS, Fowler WC, Varia MA, Walton LA, Mack Y.

Cancer. 1985 Mar 1;55(5):956-62.

PMID:
3967203
38.

Small cell carcinoma of the lung. Results of combination chemotherapy and radiation therapy.

Montana GS, Allen DG, Varia MA, Williams D, McCafferty BB.

N C Med J. 1983 Nov;44(11):711-3. No abstract available.

PMID:
6316170
39.

Carcinoma of the cervix stage IB: results of treatment with radiation therapy.

Montana GS, Fowler WC Jr, Varia MA, Walton LA, Kirsch M, Halle JS, McCafferty BB.

Int J Radiat Oncol Biol Phys. 1983 Jan;9(1):45-9.

PMID:
6841175
40.

Treatment of autochthonous rat brain tumors with fractionated radiotherapy. The effects of graded radiation doses and of combined therapy with BCNU or steroids.

Steinbok P, Mahaley MS Jr, U R, Varia MA, Lipper S, Mahaley J, Dalzell JG, Bigner DD.

J Neurosurg. 1980 Jul;53(1):68-72.

PMID:
7411210
41.

Supplemental Content

Loading ...
Support Center